Oncology trials in a shifting economical and geopolitical landscape

Webinar: Oncology trials in a shifting economical and geopolitical landscape

The pharmaceutical and biotech fields are spinning around, seeking to adapt to the current geopolitical situation and its impact on current and future oncology trials. Many trials have been shifted to other countries or regions while the complexity of managing risk increases.

Even though managing your studies in these economic times might seem challenging, all you need is thoughtful preparation and adaptation measures. Our experts will share practical tips and experience-based results on how you can do it too.

Planning your next oncology study?

Let’s talk how we can team up to conduct them effectively and ensure smooth processes.

What we will talk about?

Our experts will:

1. Give practical advice on how to plan your clinical study budget effectively;
2. Share the experience of successful geography shifts for ongoing clinical studies;
3. Discuss global tendencies in oncology clinical trials and how to adapt to them;
4. Talk about how to handle risk management.

    Duration: 50 minutes.

    Speakers:

    • Regina Auškalnienė, Chief Global Clinical Research Officer
    • Vladimir Mukovozchik, Head of Project Management
    • Oleg Kungurtsev, Head of Clinical Monitoring
    Regina Auškalnienė

    Regina Auškalnienė

    Chief Global Clinical Research Officer

    Other content that might interest you:

    No Results Found

    The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

    Biomapas joins SwedenBIO organization

    Biomapas joins SwedenBIO organization

    December 2021 Biomapas has joined the SwedenBIO organization starting November 2021. Joining SwedenBIO's mission to promote an environment bringing success and growth to the entire Swedish life science industry, we seek to walk the path in developing the life sciences...

    read more
    Challenges In Early Phase Oncology Trials

    Challenges In Early Phase Oncology Trials

    Cancer is the biggest cause of mortality globally, with 19.3 million new cases and over 10 million deaths expected in 2020. By 2040, the worldwide cancer burden is predicted to reach 28.4 million cases. Female breast cancer is the most often diagnosed type of cancer,...

    read more

    Big Enough To Cover  All Your Needs. Small Enough To Care.

    Discover the tailored solutions that Biomapas provides to accelerate your clinical trials and optimize your drug development process.

    Clinical Research

    Regulatory Affairs

    Pharmacovigilance

    Medical Information